AXGN Axogen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AXGN

Price (delayed)

$21.08

Market cap

$864.35M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.55

Enterprise value

$875M

Sector: Healthcare
Industry: Medical Devices

Highlights

The company's EPS rose by 23% YoY and by 8% QoQ
Axogen's net income has increased by 20% YoY and by 6% QoQ
Axogen's quick ratio has decreased by 7% from the previous quarter
The equity has decreased by 3.6% YoY and by 2.8% QoQ

Key stats

What are the main financial stats of AXGN
Market
Shares outstanding
41M
Market cap
$864.35M
Enterprise value
$875M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
7.17
Price to sales (P/S)
7.21
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.35
Earnings
Revenue
$119.08M
EBIT
-$20.79M
EBITDA
-$16.82M
Free cash flow
-$32.37M
Per share
EPS
-$0.55
Free cash flow per share
-$0.8
Book value per share
$2.94
Revenue per share
$2.93
TBVPS
$4.79
Balance sheet
Total assets
$197.37M
Total liabilities
$77.67M
Debt
$56.83M
Equity
$119.7M
Working capital
$112.87M
Liquidity
Debt to equity
0.47
Current ratio
6.07
Quick ratio
5.26
Net debt/EBITDA
-0.63
Margins
EBITDA margin
-14.1%
Gross margin
81.6%
Net margin
-18.7%
Operating margin
-17.5%
Efficiency
Return on assets
-11.7%
Return on equity
-18.4%
Return on invested capital
-13.3%
Return on capital employed
-11.9%
Return on sales
-17.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AXGN stock price

How has the Axogen stock price performed over time
Intraday
-1.82%
1 week
-3.21%
1 month
11.83%
1 year
161.86%
YTD
17.77%
QTD
4.05%

Financial performance

How have Axogen's revenue and profit performed over time
Revenue
$119.08M
Gross profit
$97.14M
Operating income
-$20.89M
Net income
-$22.25M
Gross margin
81.6%
Net margin
-18.7%
AXGN's operating margin is up by 37% YoY and by 15% QoQ
Axogen's operating income has increased by 30% YoY and by 10% from the previous quarter
The company's net margin rose by 28% YoY and by 12% QoQ
Axogen's net income has increased by 20% YoY and by 6% QoQ

Growth

What is Axogen's growth rate over time

Valuation

What is Axogen stock price valuation
P/E
N/A
P/B
7.17
P/S
7.21
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.35
The company's EPS rose by 23% YoY and by 8% QoQ
AXGN's P/B is 78% below its 5-year quarterly average of 32.2 but 46% above its last 4 quarters average of 4.9
The equity has decreased by 3.6% YoY and by 2.8% QoQ
AXGN's P/S is 36% above its last 4 quarters average of 5.3 but 25% below its 5-year quarterly average of 9.6
The revenue has grown by 11% YoY and by 6% from the previous quarter

Efficiency

How efficient is Axogen business performance
Axogen's return on invested capital has surged by 52% YoY and by 23% QoQ
The ROA has increased by 36% YoY and by 13% from the previous quarter
The company's return on sales rose by 32% YoY and by 13% QoQ
Axogen's ROE has increased by 12% YoY and by 6% from the previous quarter

Dividends

What is AXGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AXGN.

Financial health

How did Axogen financials performed over time
The total assets is 154% higher than the total liabilities
The total assets rose by 36% YoY
Axogen's quick ratio has decreased by 7% from the previous quarter
The company's debt is 53% lower than its equity
The equity has decreased by 3.6% YoY and by 2.8% QoQ
The debt to equity has grown by 2.2% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.